← Back to Search

PrEP Awareness Program for HIV Prevention in Black Women

N/A

Waitlist Available

Led By Amy Corneli, MPH, PhD

Research Sponsored by Duke University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 5 years

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to measure the effectiveness of a program that encourages conversations about PrEP for Black women. It will use interviews, reviews, records and social media metrics.

Who is the study for?

This trial is for LSU GYN residents and Black cisgender women who meet the CDC guidelines for PrEP, a medication that helps prevent HIV. It's designed to evaluate an initiative aimed at increasing PrEP use among these women in New Orleans.

What is being tested?

The 'Start the Conversation' Initiative includes training for GYN residents and a social media campaign, both aiming to boost awareness and uptake of PrEP among eligible Black cisgender women to prevent HIV infection.

What are the potential side effects?

Since this study focuses on implementation rather than drug effects, it doesn't directly involve side effects from interventions. However, general side effects of PrEP can include nausea, headaches, stomach pain, and weight loss.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 5 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 5 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Start the Conversation PackageExperimental Treatment2 Interventions

The pre-intervention phase will last for 4 months (months 1-4). The only study activity during the pre-intervention phase is the collection of routine PrEP uptake data to establish a baseline for PrEP prescribing at the GYN residency clinics and local PrEP clinics. The implementation of the combined-care model at the LSU GYN residency clinic at UMCNO for 10 months (months 5-14). Then we will add implementation of the social media campaign in the NOLA area for 4 months (months 5-18); implementation of the combined-care model at LSU GYN residency clinic at UMCNO will continue. The layered approach allows for an opportunity to assess the effect of the combined-care model, and subsequently, to what extent the social media campaign additionally engages Black women and builds demand for PrEP.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Social Media Campaign

2022

N/A

~57910

Do I qualify?Apply below to find out